Benevento F - Search Results

1

Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib.

Granito A, Marinelli S, Negrini G, Menetti S, Benevento F, Bolondi L. Granito A, et al. Among authors: benevento f. Therap Adv Gastroenterol. 2016 Mar;9(2):240-9. doi: 10.1177/1756283X15618129. Therap Adv Gastroenterol. 2016. PMID: 26929785 Free PMC article. Review.

2

Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group.

Leoni S, Piscaglia F, Serio I, Terzi E, Pettinari I, Croci L, Marinelli S, Benevento F, Golfieri R, Bolondi L. Leoni S, et al. Among authors: benevento f. Dig Liver Dis. 2014 Jun;46(6):549-55. doi: 10.1016/j.dld.2014.02.012. Epub 2014 Mar 14. Dig Liver Dis. 2014. PMID: 24630947

3

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.

Golfieri R, Giampalma E, Renzulli M, Cioni R, Bargellini I, Bartolozzi C, Breatta AD, Gandini G, Nani R, Gasparini D, Cucchetti A, Bolondi L, Trevisani F; PRECISION ITALIA STUDY GROUP. Golfieri R, et al. Br J Cancer. 2014 Jul 15;111(2):255-64. doi: 10.1038/bjc.2014.199. Epub 2014 Jun 17. Br J Cancer. 2014. PMID: 24937669 Free PMC article. Clinical Trial.

4

Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure.

Granito A, Marinelli S, Terzi E, Piscaglia F, Renzulli M, Venerandi L, Benevento F, Bolondi L. Granito A, et al. Among authors: benevento f. Dig Liver Dis. 2015 Jun;47(6):518-22. doi: 10.1016/j.dld.2015.03.010. Epub 2015 Mar 18. Dig Liver Dis. 2015. PMID: 25861840

5

Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma.

Tovoli F, De Lorenzo S, Samolsky Dekel BG, Piscaglia F, Benevento F, Brandi G, Bolondi L. Tovoli F, et al. Among authors: benevento f. Liver Int. 2018 Feb;38(2):278-284. doi: 10.1111/liv.13546. Epub 2017 Sep 4. Liver Int. 2018. PMID: 28792650

6

Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.

Tovoli F, Renzulli M, Negrini G, Brocchi S, Ferrarini A, Andreone A, Benevento F, Golfieri R, Morselli-Labate AM, Mastroroberto M, Badea RI, Piscaglia F. Tovoli F, et al. Among authors: benevento f. Eur Radiol. 2018 Sep;28(9):3611-3620. doi: 10.1007/s00330-018-5393-3. Epub 2018 Apr 9. Eur Radiol. 2018. PMID: 29633000

7

Systemic treatments for hepatocellular carcinoma: challenges and future perspectives.

Tovoli F, Negrini G, Benevento F, Faggiano C, Goio E, Granito A. Tovoli F, et al. Among authors: benevento f. Hepat Oncol. 2018 Feb 8;5(1):HEP01. doi: 10.2217/hep-2017-0020. eCollection 2018 Jan. Hepat Oncol. 2018. PMID: 30302192 Free PMC article. Review.

8

An update of treatments of hepatocellular carcinoma in patients refractory to sorafenib.

Ielasi L, Sansone V, Granito A, Benevento F, De Lorenzo S, Tovoli F. Ielasi L, et al. Among authors: benevento f. Drugs Today (Barc). 2018 Oct;54(10):615-627. doi: 10.1358/dot.2018.54.10.2880176. Drugs Today (Barc). 2018. PMID: 30398482 Review.

9

MiR-30e-3p Influences Tumor Phenotype through MDM2/TP53 Axis and Predicts Sorafenib Resistance in Hepatocellular Carcinoma.

Gramantieri L, Pollutri D, Gagliardi M, Giovannini C, Quarta S, Ferracin M, Casadei-Gardini A, Callegari E, De Carolis S, Marinelli S, Benevento F, Vasuri F, Ravaioli M, Cescon M, Piscaglia F, Negrini M, Bolondi L, Fornari F. Gramantieri L, et al. Among authors: benevento f. Cancer Res. 2020 Apr 15;80(8):1720-1734. doi: 10.1158/0008-5472.CAN-19-0472. Epub 2020 Feb 3. Cancer Res. 2020. PMID: 32015093

10

Prognostic Role of Blood Eosinophil Count in Patients with Sorafenib-Treated Hepatocellular Carcinoma.

Orsi G, Tovoli F, Dadduzio V, Vivaldi C, Brunetti O, Ielasi L, Conti F, Rovesti G, Gramantieri L, Rizzato MD, Pecora I, Argentiero A, Teglia F, Lonardi S, Salani F, Granito A, Zagonel V, Marisi G, Cabibbo G, Foschi FG, Benevento F, Cucchetti A, Piscaglia F, Cascinu S, Scartozzi M, Casadei-Gardini A. Orsi G, et al. Among authors: benevento f. Target Oncol. 2020 Dec;15(6):773-785. doi: 10.1007/s11523-020-00757-3. Target Oncol. 2020. PMID: 33044683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

32 results

Search Page